Enterprise Hematopathology Director: Equity & Growth

Isac Net; Durham (NC); Presencial; USD 250.000 - 400.000; Jornada completa

Ventajas ofrecidas por este puesto de trabajo

Equity participation

Annual bonus

Relocation assistance

License reimbursement

Descripción de la vacante

NeoGenomics is seeking an Enterprise Director of Hematopathology to provide strategic medical leadership across multiple sites, overseeing hematopathology services, including morphology, flow cytometry, FISH, cytogenetics, and molecular pathology integration.

The role emphasizes standards for diagnostic excellence, quality, and enterprise-wide collaboration with operations, product development, and commercial teams, with relocation support where applicable.

Formación

• MD/DO with board certification in Anatomic and/or Clinical Pathology required.
• Hematopathology subspecialty boards preferred.

Responsabilidades

• Provide enterprise leadership for hematopathology services across multiple sites.
• Drives diagnostic excellence in morphology, flow cytometry, and integrated reporting.
• Partner with cytogenetics, FISH, and molecular pathology leaders to ensure best-in-class reporting.
• Staff hematopathology leaders across sites and establish consistent policies for workload and case assignment.
• Lead organization-wide hematopathology initiatives and training as needed.
• Support digital transformation and cross-functional collaboration within the enterprise.
• Perform onsite diagnostic interpretation across modalities for hematopathology cases.

Conocimientos

Leadership

Strategic thinking

Collaboration

Travel readiness

Educación

MD/DO with board certification in Anatomic or Clinical Pathology

Hematopathology subspecialty boards

Herramientas

FISH

Cytogenetics

Molecular pathology

Descripción del empleo

NeoGenomics is seeking an Enterprise Director of Hematopathology to provide strategic medical leadership across multiple sites, overseeing hematopathology services, including morphology, flow cytometry, FISH, cytogenetics, and molecular pathology integration.

The role emphasizes standards for diagnostic excellence, quality, and enterprise-wide collaboration with operations, product development, and commercial teams, with relocation support where applicable.